MEI Pharma, Inc. (MEIP) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
MEIP currently has 35.7M outstanding shares. with significant dilution risk as 70.8M authorized shares could dilute existing holders by 198.2%. The company has significantly diluted shareholders by 399.25% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 13, 2026 |
10-Q filing | 35.7M shares outstanding |
36M | 71M |
| Nov 14, 2025 |
10-Q filing | 36.8M shares outstanding |
37M | 70M |
| Sep 15, 2025 |
8-K filing: On September 10, 2025, an investor exercised 1,595,000 pre-funded warrants in a cashless exercise to purchase 1,594,944 shares of Lite Strategy, Inc.'s common stock. |
33M | 74M |
| Aug 26, 2025 |
S-3/A filing: This prospectus relates to the resale of common stock by selling stockholders. |
33M | 74M |
| Aug 06, 2025 |
S-3 filing: This prospectus relates to the resale of common stock, pre-funded warrants, and warrants by selling stockholders. |
32M | 74M |
| Jul 30, 2025 |
8-K filing: On July 24, 2024, an investor exercised pre-funded warrants to purchase 2,084,509 shares of common stock for an aggregate amount of $208.45. ($0.0M proceeds) |
6.7M | 68M |
| Jul 22, 2025 |
8-K filing: MEI Pharma, Inc. completed a private placement offering on July 22, 2025, issuing shares of common stock and pre-funded warrants to investors, while also entering into agreements with Titan Partners Group LLC, GSR Strategies LLC, Green Dragon Investments LLC, and Green Grass Ventures. ($79.32M proceeds) |
6.7M | 68M |
| May 13, 2025 |
10-Q filing | 6.7M shares outstanding |
6.7M | 68M |
| Feb 12, 2025 |
10-Q filing | 6.7M shares outstanding |
6.7M | 68M |
| Nov 12, 2024 |
10-Q filing | 6.7M shares outstanding |
6.7M | 68M |
| Sep 19, 2024 |
10-K filing | 6.7M shares outstanding |
6.7M | 68M |
| May 09, 2024 |
10-Q filing | 6.7M shares outstanding |
6.7M | 68M |
| Feb 20, 2024 |
S-3 filing: MEI Pharma, Inc. is filing an S-3 to offer up to $100,000,000 of common stock, preferred stock, warrants, rights, or units. |
6.7M | 68M |
| Feb 13, 2024 |
10-Q filing | 6.7M shares outstanding |
6.7M | 68M |
| Nov 09, 2023 |
10-Q filing | 6.7M shares outstanding |
6.7M | 68M |
| Sep 26, 2023 |
10-K filing | 6.7M shares outstanding |
6.7M | 68M |
| May 11, 2023 |
10-Q filing | 6.7M shares outstanding |
6.7M | 68M |
| Feb 09, 2023 |
10-Q filing | 133.3M shares outstanding |
130M | 0 |
| Nov 14, 2022 |
10-Q filing | 133.3M shares outstanding |
130M | 0 |
| Sep 08, 2022 |
10-K filing | 125.1M shares outstanding |
130M | 0 |
| May 23, 2022 |
10-Q filing | 133.1M shares outstanding |
130M | 0 |
| Feb 10, 2022 |
10-Q filing | 128.2M shares outstanding |
130M | 0 |
| Nov 10, 2021 |
10-Q filing | 112.7M shares outstanding |
110M | 0 |
| Sep 02, 2021 |
10-K filing | 112.5M shares outstanding |
110M | 0 |
| May 06, 2021 |
10-Q filing | 112.6M shares outstanding |
110M | 0 |
| Feb 04, 2021 |
10-Q filing | 112.5M shares outstanding |
110M | 0 |
| Nov 10, 2020 |
10-Q filing | 112.4M shares outstanding |
110M | 0 |
| Sep 09, 2020 |
10-K filing | 111.5M shares outstanding |
110M | 0 |
| May 07, 2020 |
S-3 filing: MEI Pharma, Inc. may offer up to $200,000,000 aggregate dollar amount of common stock, preferred stock and warrants in one or more offerings. |
110K | 74M |
| May 07, 2020 |
10-Q filing | 106.0M shares outstanding |
110M | 0 |
| Feb 06, 2020 |
10-Q filing | 0.1M shares outstanding |
110K | 0 |